Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126280931 | 12628093 | 1 | I | 20160627 | 20160727 | 20160808 | 20160808 | EXP | AR-UCBSA-2016028730 | UCB | 46.49 | YR | F | Y | 0.00000 | 20160808 | CN | AR | AR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126280931 | 12628093 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 200 MG, EV 2 WEEKS(QOW) | U | 125160 | 200 | MG | SOLUTION FOR INJECTION | QOW | |||||
126280931 | 12628093 | 2 | C | METHOTREXATE. | METHOTREXATE | 1 | 20 MG, WEEKLY (QW) | U | 0 | 20 | MG | /wk | |||||||
126280931 | 12628093 | 3 | C | Meprednisone | MEPREDNISONE | 1 | 4 MG, ONCE DAILY (QD) | U | 0 | 4 | MG | QD | |||||||
126280931 | 12628093 | 4 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | 70 MG, WEEKLY (QW) | U | 0 | 70 | MG | /wk | |||||||
126280931 | 12628093 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 100 MCG DAILY | U | 0 | ||||||||||
126280931 | 12628093 | 6 | C | AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Oral | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126280931 | 12628093 | 1 | Rheumatoid arthritis |
126280931 | 12628093 | 2 | Product used for unknown indication |
126280931 | 12628093 | 3 | Product used for unknown indication |
126280931 | 12628093 | 4 | Product used for unknown indication |
126280931 | 12628093 | 5 | Product used for unknown indication |
126280931 | 12628093 | 6 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126280931 | 12628093 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126280931 | 12628093 | Pneumonia | |
126280931 | 12628093 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126280931 | 12628093 | 1 | 201601 | 201606 | 0 | |
126280931 | 12628093 | 2 | 2005 | 0 | ||
126280931 | 12628093 | 3 | 2005 | 0 | ||
126280931 | 12628093 | 5 | 2013 | 0 |